DENYES NANCY (General Counsel) sold 15.5% of their position (4.65K shares) of ATYR PHARMA INC on the open market
Open‑market sale worth $2.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/20/2019ACC: 0001209191-19-031424
Officer· General Counsel
Since Feb 2019
-4.65K
Net shares
Net seller
$2.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.50K acquired · 17.15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.50K
Price / share
—
Trade value
—
% of position
71.4%
5/16/2019
17.50K→30K
Common Stock
Direct
Shares
−4.65K
Price / share
$0.45
Trade value
$2.09K
% of position
15.5%
5/17/2019
30K→25.35K
Total
Net shares
+7.85K
Net value
-$2.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2019 | M · Option Exercise | +12.50K | — | — | 71.4% | 17.50K | 30K |
| Common Stock Direct | 5/17/2019 | S · Sale | −4.65K | $0.45 | $2.09K | 15.5% | 30K | 25.35K |
| Total | +7.85K | -$2.09K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
12.50K shares
Shares
−12.50K
Strike price
0.00
Held after
12.50K
Exercisable
—
5/16/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock12.50K shares | 5/16/2019 | M · Option Exercise | −12.50K | 0.00 | — | 12.50K |